EdgarLookup

Aprea Therapeutics, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
5AM Partners IV, LLC Sale 10,200 $35.15 $358,530 90,572 May 19, 2020
ROCKLAGE SCOTT M Sale 244,800 $35.15 $8,604,720 2,173,748 May 19, 2020
Versant Vantage I GP, L.P. Other 1,750 May 18, 2020
Versant Ophthalmic Affiliates I, L.P. Other 16,428 May 18, 2020
KDev Investments AB Sale 210,548 $31.25 $6,579,625 2,234,289 Apr 13, 2020
SCHADE CHRISTIAN S President & CEO Purchase 1,000 $15.00 $15,000 1,000 Oct 7, 2019
Coiante Scott M SVP, Chief Financial Officer Purchase 2,500 $15.00 $37,500 2,500 Oct 7, 2019
Attar Eyal C. SVP, Chief Medical Officer Purchase 200 $15.00 $3,000 200 Oct 7, 2019
Korbel Gregory Alan VP of Business Dev't Purchase 500 $15.00 $7,500 500 Oct 7, 2019
HENNEMAN JOHN B III Purchase 5,000 $15.00 $75,000 5,000 Oct 7, 2019
Magni Guido Purchase 6,500 $15.00 $97,500 6,500 Oct 7, 2019
ROCKLAGE SCOTT M C 79,746 80,253 Oct 7, 2019
KDev Investments AB C 1,600,559 2,444,837 Oct 7, 2019
Seizinger Bernd R. Option Exercise 263,970 $0.07 $18,478 263,970 Oct 7, 2019
Christenson Johan Purchase 266,667 $15.00 $4,000,005 2,366,104 Oct 7, 2019
Versant Ventures V GP-GP (Canada), Inc. C 512,995 2,519,323 Oct 7, 2019
Versant Vantage I GP-GP, LLC C 1,993,658 2,006,328 Oct 7, 2019
HealthCap VII, L.P. C 1,661,382 1,671,941 Oct 7, 2019
Redmile Group, LLC Purchase 400,000 $15.00 $6,000,000 2,268,718 Oct 7, 2019
5AM Ventures IV, L.P. C 20,519 100,772 Oct 7, 2019